GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Danaher Corp (NYSE:DHR) » Definitions » Cyclically Adjusted PS Ratio

DHR (Danaher) Cyclically Adjusted PS Ratio : 5.59 (As of May. 28, 2025)


View and export this data going back to 1986. Start your Free Trial

What is Danaher Cyclically Adjusted PS Ratio?

As of today (2025-05-28), Danaher's current share price is $189.01. Danaher's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was $33.84. Danaher's Cyclically Adjusted PS Ratio for today is 5.59.

The historical rank and industry rank for Danaher's Cyclically Adjusted PS Ratio or its related term are showing as below:

DHR' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 2.66   Med: 5.76   Max: 10.5
Current: 5.59

During the past years, Danaher's highest Cyclically Adjusted PS Ratio was 10.50. The lowest was 2.66. And the median was 5.76.

DHR's Cyclically Adjusted PS Ratio is ranked worse than
78.03% of 132 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.08 vs DHR: 5.59

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Danaher's adjusted revenue per share data for the three months ended in Mar. 2025 was $7.965. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $33.84 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Danaher Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Danaher's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Danaher Cyclically Adjusted PS Ratio Chart

Danaher Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.51 10.16 7.62 7.28 6.86

Danaher Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.74 7.73 8.59 6.86 6.06

Competitive Comparison of Danaher's Cyclically Adjusted PS Ratio

For the Diagnostics & Research subindustry, Danaher's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Danaher's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Danaher's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Danaher's Cyclically Adjusted PS Ratio falls into.


;
;

Danaher Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Danaher's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=189.01/33.84
=5.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Danaher's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Danaher's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=7.965/134.9266*134.9266
=7.965

Current CPI (Mar. 2025) = 134.9266.

Danaher Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 6.893 100.684 9.237
201509 5.027 100.392 6.756
201512 6.201 99.792 8.384
201603 5.629 100.470 7.559
201606 6.069 101.688 8.053
201609 5.892 101.861 7.805
201612 6.531 101.863 8.651
201703 5.960 102.862 7.818
201706 6.394 103.349 8.348
201709 6.418 104.136 8.316
201712 3.213 104.011 4.168
201803 6.618 105.290 8.481
201806 7.020 106.317 8.909
201809 6.830 106.507 8.652
201812 3.543 105.998 4.510
201903 5.874 107.251 7.390
201906 6.106 108.070 7.623
201909 6.003 108.329 7.477
201912 6.702 108.420 8.341
202003 6.135 108.902 7.601
202006 7.375 108.767 9.149
202009 8.124 109.815 9.982
202012 9.332 109.897 11.457
202103 9.329 111.754 11.263
202106 9.807 114.631 11.543
202109 9.944 115.734 11.593
202112 4.738 117.630 5.435
202203 10.422 121.301 11.593
202206 10.531 125.017 11.366
202209 10.392 125.227 11.197
202212 4.802 125.222 5.174
202303 8.070 127.348 8.550
202306 7.939 128.729 8.321
202309 7.540 129.860 7.834
202312 8.585 129.419 8.950
202403 7.742 131.776 7.927
202406 7.736 132.554 7.874
202409 7.949 133.029 8.062
202412 8.975 133.157 9.094
202503 7.965 134.927 7.965

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Danaher  (NYSE:DHR) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Danaher Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Danaher's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Danaher Business Description

Address
2200 Pennsylvania Avenue, North West, Suite 800W, Washington, DC, USA, 20037-1701
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
Executives
Alan G Spoon director 1150 15TH ST NW, WASHINGTON DC 20071
Brian W Ellis officer: Senior Vice President - GC 2200 PENNSYLVANIA AVENUE, NW, WASHINGTON DC 20037
Daniel Raskas officer: VP-Corporate Development 2099 PENNSYLVANIA AVENUE, NORTHWEST, WASHINGTON DC 20006
Georgeann Couchara officer: SVP, Human Resources 2200 PENNSYLVANIA AVENUE, NW, SUITE 800W, WASHINGTON DC 20037
Linda Filler director 2200 PENNSYLVANIA AVE NW, SUITE 800W, WASHINGTON DC 20037
Matthew Mcgrew officer: EVP & Chief Financial Officer 2200 PENNSYLVANIA AVENUE, NW, SUITE 800 W, WASHINGTON DC 20010
Rainer Blair officer: Executive Vice President 2200 PENNSYLVANIA AVENUE, NW, SUITE 800W, WASHINGTON DC 20037
Joakim Weidemanis officer: Executive Vice President 2200 PENNSYLVANIA AVENUE, SUITE 800W, WASHINGTON DC 20037
Walter G Lohr director DANAHER CORP, 2099 PENNSYLVANIA AVE NW 12TH FL, WASHINGTON DC 20006
Teri List director 2200 PENNSYLVANIA AVENUE, SUITE 800W, WASHINGTON DC 20037
Jose-carlos Gutierrez-ramos officer: SVP, Chief Scientific Officer C/O MOMENTA PHARMACEUTICALS, INC., 675 WEST KENDALL STREET, CAMBRIDGE MA 02142
Raymond C Stevens director 2200 PENNSYLVANIA AVENUE, SUITE 800W, WASHINGTON DC 20037
Jennifer Honeycutt officer: Executive Vice President 2200 PENNSYLVANIA AVENUE, SUITE 800W, WASHINGTON DC 20037
Feroz Dewan director C/O ARENA HOLDINGS MANAGEMENT LLC, 119 FIFTH AVENUE - 8TH FLOOR, NEW YORK NY 10003
Mitchell P Rales director, officer: Chairman of Exec. Committee 11790 GLEN ROAD, POTOMAC MD 20854